Carregant...
Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
Renal cell carcinoma (RCC) has traditionally been regarded as radioresistant tumor based on preclinical data and negative clinical trials using conventional fractionated radiotherapy. However, there is emerging evidence that radiotherapy delivered in few fractions with high single-fraction and total...
Guardat en:
| Publicat a: | Clin Transl Radiat Oncol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6630187/ https://ncbi.nlm.nih.gov/pubmed/31341985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctro.2019.04.012 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|